Biomerica Inc (BMRA) Stock Price, Quote & News

Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 645 2111

Fax: 949 553 1231

Website: www.biomerica.com

Address:

17571 Von Karman Avenue, Irvine, United States

kshonstocks Sep. 8 at 5:01 PM

$BMRA good looking chart also

0 · Reply

zampy Sep. 5 at 2:07 PM

$BMRA My goodness hard to buy size...Float was bought up 4 days ago...We will know who filed soon...

0 · Reply

BigGreenCandle Sep. 3 at 2:12 PM

$BMRA Micro float with Insiders and Institutions on board. Would love to see a move to the $6 range.

0 · Reply

LewisDaKat Sep. 1 at 4:31 PM

$BMRA Biomerica Reports Fiscal 2026 Year-End Financial Results https://marketwirenews.com/stock/bmra/news/biomerica-reports-fiscal-2026-year-end-financial-res-7540548467436623.html?utm_source=stocktwits

0 · Reply

focafoca99 Sep. 1 at 12:37 PM

$BMRA disclosed FY2026 results with net loss narrowing to $3.8M and a $2.23M private placement financing.

0 · Reply

STACKD0E Sep. 1 at 12:22 PM

$BMRA $BFLY $NVTS 👁

0 · Reply

MrTicker Sep. 1 at 12:20 PM

$BMRA Biomerica Reports Fiscal 2026 Year-End Financial Results GLOBENEWSWIRE 7:19 AM ET 9/1/2026 Fiscal 2026 fourth quarter net sales increased approximately 17% compared to the fourth quarter of fiscal 2025 Full-year net loss improved by approximately 24% to approximately $3.8 million InFoods IBS update: 100% of all initial valid claims processed to date have been paid at the full CMS payment rate of $300 Research and development expenses decreased 23% as key programs transition toward commercialization Subsequent to fiscal year-end: completed a $2.23 million financing with no warrants or discounted securities, including participation from B. Riley Principal Capital, B. Riley executives and all members of the board of directors Engaged B. Riley Securities, Inc. to support the Board's ongoing evaluation of potential Strategic Opportunities, Including Partnerships and Business Combinations

0 · Reply

MultiversalTruth Aug. 28 at 3:03 AM

$BMRA newbie here.. can anyone tell me offhand how many shares were outstanding before the financing?

0 · Reply

CEOBuysDisclosures Aug. 27 at 11:30 PM

$BMRA CEO purchased 31,250 shares at $1.60 for a total of $50,000. Irani Zackary S. now owns 242,570 shares. https://ceo-buys.com

0 · Reply

FilingTracker Aug. 27 at 9:31 PM

$BMRA Insider purchases including: https://filingtracker.ai/filing/73290/0001493152-26-040454?doc=ownership.xml

0 · Reply

Biomerica Reports Fiscal 2026 Year-End Financial Results

2026-08-27T12:26:13.000Z - 20 days ago

Biomerica prices 1.39M shares at $1.60 in private placement

2026-08-27T12:25:47.000Z - 20 days ago

Biomerica engages B. Riley as its exclusive financial advisor

Aug 27, 2026, 8:19 AM EDT - 20 days ago

Biomerica Announces $2.23 Million Financing

2026-05-28T15:16:45.000Z - 3 months ago

Biomerica enters master services agreement with life sciences company

May 28, 2026, 8:19 AM EDT - 3 months ago

Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development

Apr 29, 2026, 8:19 AM EDT - 4 months ago

Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

2026-04-16T13:12:25.000Z - 5 months ago

Biomerica announces MAC confirms inFoods IBS test is eligible for coverage

Apr 16, 2026, 8:19 AM EDT - 5 months ago

Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway

Apr 14, 2026, 8:19 AM EDT - 5 months ago

Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs

Apr 13, 2026, 6:57 PM EDT - 5 months ago

Biomerica Reports Third Quarter Fiscal 2026 Financial Results

2026-03-18T12:37:33.000Z - 6 months ago

Biomerica receives first commercial order for Hp Detect

Mar 18, 2026, 8:19 AM EDT - 6 months ago

Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe

2026-03-05T13:37:21.000Z - 6 months ago

Biomerica receives MHRA registration for hp+detect

Mar 5, 2026, 8:19 AM EST - 6 months ago

Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain

2026-02-26T13:25:27.000Z - 6 months ago

Biomerica reports responder analysis results from study of inFoods IBS

Feb 26, 2026, 8:19 AM EST - 6 months ago

Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

2026-02-18T13:25:25.000Z - 7 months ago

Biomerica announces Vietnam approved EZ Detect for nationwide distribution

Feb 18, 2026, 8:19 AM EST - 7 months ago

Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution

Jan 14, 2026, 5:17 PM EST - 8 months ago

Biomerica Reports Second Quarter Fiscal 2026 Financial Results

2025-12-23T13:25:08.000Z - 8 months ago

Biomerica announces CMS Medicare payment rate of $300 for IBS test

Dec 23, 2025, 8:19 AM EST - 8 months ago

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

2025-12-11T13:25:25.000Z - 9 months ago

Biomerica’s complete screening test portfolio authorized in Egypt

Dec 11, 2025, 8:08 AM EST - 9 months ago

Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio

2025-11-25T13:25:36.000Z - 9 months ago

Biomerica announces inFoods IBS product featured in Biotherapeutics Quarterly

Nov 25, 2025, 8:19 AM EST - 9 months ago

Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

2025-11-06T13:46:26.000Z - 10 months ago

Biomerica expands CDMO services to meet growing market demand

Nov 6, 2025, 8:19 AM EST - 10 months ago

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

2025-10-16T12:27:48.000Z - 11 months ago

Biomerica, Henry Schein enter marketing services agreement for inFoods IBS test

HSIC

Oct 16, 2025, 8:19 AM EDT - 11 months ago

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

2025-10-15T13:30:20.000Z - 11 months ago

Biomerica reports Q1 EPS 0c vs. (8c) last year

Oct 15, 2025, 9:27 AM EDT - 11 months ago

Biomerica Reports First Quarter Fiscal 2026 Financial Results

2025-10-08T12:30:43.000Z - 11 months ago

Biomerica appoints Gary Huff to board of directors

Oct 8, 2025, 8:19 AM EDT - 11 months ago

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

2025-09-09T12:20:29.000Z - 1 year ago

Biomerica announces launch of inFoods IBS Trigger Food Navigator

Sep 9, 2025, 8:08 AM EDT - 1 year ago

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

2025-09-03T12:26:22.000Z - 1 year ago

Biomerica announces UAE Ministry of Health approved its Fortel Kidney Test

Sep 3, 2025, 8:19 AM EDT - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Aug 29, 2025, 5:12 PM EDT - 1 year ago

Biomerica Reports Fiscal 2025 Year End Results

2025-08-14T12:30:42.000Z - 1 year ago

Biomerica announces UAE approved its Fortel Ulcer Test for home use

Aug 14, 2025, 8:19 AM EDT - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

2025-07-02T12:16:08.000Z - 1 year ago

Biomerica announces inFoods IBS received CPT PLA code

Jul 2, 2025, 8:08 AM EDT - 1 year ago

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Jun 26, 2025, 8:19 AM EDT - 1 year ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Jun 6, 2025, 9:30 AM EDT - 1 year ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Jun 5, 2025, 8:19 AM EDT - 1 year ago

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

May 22, 2025, 8:19 AM EDT - 1 year ago

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

May 7, 2025, 8:19 AM EDT - 1 year ago

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

Apr 23, 2025, 8:19 AM EDT - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

Apr 17, 2025, 8:19 AM EDT - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Apr 16, 2025, 9:00 AM EDT - 1 year ago

Biomerica Announces Reverse Stock Split

Feb 26, 2025, 8:19 AM EST - 1 year ago

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Feb 19, 2025, 8:19 AM EST - 1 year ago

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Jan 16, 2025, 8:19 AM EST - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Jan 15, 2025, 8:19 AM EST - 1 year ago

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Nov 21, 2024, 8:19 AM EST - 1 year ago

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nov 7, 2024, 9:09 AM EST - 1 year ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Oct 30, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Oct 16, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Sep 4, 2024, 8:19 AM EDT - 2 years ago

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Aug 29, 2024, 9:00 AM EDT - 2 years ago

Biomerica Reports Fiscal 2024 Year End Results

Jul 1, 2024, 7:47 AM EDT - 2 years ago

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

May 13, 2024, 8:19 AM EDT - 2 years ago

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

Apr 29, 2024, 8:19 AM EDT - 2 years ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Apr 15, 2024, 7:47 AM EDT - 2 years ago

Biomerica provides update on inFoods® IBS expansion

Apr 12, 2024, 7:23 PM EDT - 2 years ago

Biomerica Reports Third Quarter 2024 Financial Results

Mar 28, 2024, 8:19 AM EDT - 2 years ago

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Feb 21, 2024, 8:19 AM EST - 2 years ago

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Jan 23, 2024, 8:19 AM EST - 2 years ago

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

kshonstocks Sep. 8 at 5:01 PM

$BMRA good looking chart also

0 · Reply

zampy Sep. 5 at 2:07 PM

$BMRA My goodness hard to buy size...Float was bought up 4 days ago...We will know who filed soon...

0 · Reply

BigGreenCandle Sep. 3 at 2:12 PM

$BMRA Micro float with Insiders and Institutions on board. Would love to see a move to the $6 range.

0 · Reply

LewisDaKat Sep. 1 at 4:31 PM

0 · Reply

focafoca99 Sep. 1 at 12:37 PM

$BMRA disclosed FY2026 results with net loss narrowing to $3.8M and a $2.23M private placement financing.

0 · Reply

STACKD0E Sep. 1 at 12:22 PM

$BMRA $BFLY $NVTS 👁

0 · Reply

MrTicker Sep. 1 at 12:20 PM

0 · Reply

MultiversalTruth Aug. 28 at 3:03 AM

$BMRA newbie here.. can anyone tell me offhand how many shares were outstanding before the financing?

0 · Reply

CEOBuysDisclosures Aug. 27 at 11:30 PM

$BMRA CEO purchased 31,250 shares at $1.60 for a total of $50,000. Irani Zackary S. now owns 242,570 shares. https://ceo-buys.com

0 · Reply

FilingTracker Aug. 27 at 9:31 PM

$BMRA Insider purchases including: https://filingtracker.ai/filing/73290/0001493152-26-040454?doc=ownership.xml

0 · Reply

topstockalerts Aug. 27 at 9:29 PM

Top Gainers PT2 $USDE $WNW $OKTA $GSUN $BMRA

0 · Reply

Hurtadogoalkeeper Aug. 27 at 8:17 PM

$BMRA For me, the next B. Riley news is much more important than the quarterly results. If a specific buyer or transaction is announced, BMRA could move several dozen percent from these levels.

1 · Reply

topstockalerts Aug. 27 at 7:45 PM

$BMRA 💰💰💰💰

0 · Reply

prismmarketview Aug. 27 at 7:19 PM

$BMRA — the numbers: → $2.23M raised, 1.39M shares @ $1.60 → No warrants → ~30.4% dilution (4.59M shares outstanding pro forma) → CEO + full board participated The real story: B. Riley now exclusive adviser on a strategic review — sale, merger, partnership, spin-off all possible outcomes. Nothing signed. Nothing sized. Watch for: cash runway updates, inFoods milestones, any named counterparty. $BMRA #MedTech https://prismmarketview.com/biomerica-secures-2-23-million-and-launches-strategic-review-to-unlock-shareholder-value/

0 · Reply

Barryman1 Aug. 27 at 7:19 PM

$BMRA ready for 📈🔥

0 · Reply

topstockalerts Aug. 27 at 7:12 PM

Top Gainers PT2 $WNW $USDE.X $OKTA $BMRA $GSUN

0 · Reply

Futtlappl Aug. 27 at 6:59 PM

$BMRA now can we see a steady increase in SP over the next months?

0 · Reply

MrTicker Aug. 27 at 4:55 PM

$IGC $SOAR broke out of .19 range now .21 , IGC .34 on tap.. holding $BMRA break out on news.. $2.35 in play.. lets see what the afternoon brings us

0 · Reply

Hurtadogoalkeeper Aug. 27 at 4:42 PM

$BMRA Q4 earnings soon. Hyperbullish!

0 · Reply

PepeDeFraud Aug. 27 at 4:17 PM

$BMRA awe over so soon, no fun like $CELU

1 · Reply

MrTicker Aug. 27 at 4:10 PM

$BMRA small pullback before next leg up $2.35

0 · Reply

Market Cap	7.11M
Revenue (ttm)	4.45M
Net Income (ttm)	-3.78M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-84.94%
Debt to Equity Ratio	0.00

Volume	13,600
Avg Vol	82,186
Day's Range	N/A - N/A
Shares Out	3.09M
Stochastic %K	89%
Beta	0.37
Analysts	Strong Sell
Price Target	$9.00